Next, we determined the accuracy of CTNNB1 32–37 qPCR assay by detecting mutations in liver tissue DNA from patients with hepatitis (n = 35), cirrhosis (n = 35), or HCC (n = 73) and validating by Sanger sequencing. This evidence concerns the gene CTNNB1 and Cirrhosis.